Clinical Trials Directory

Trials / Sponsors / Guangzhou Lupeng Pharmaceutical Company LTD.

Guangzhou Lupeng Pharmaceutical Company LTD.

Industry · 12 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutin
Clinical Pharmacology
Phase 12026-03-05
RecruitingA Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory
Mantle Cell Lymphoma
Phase 32026-02-05
RecruitingA Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Phase 22025-11-27
RecruitingPhase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin L
B-cell Non-Hodgkin Lymphoma
Phase 12024-04-10
CompletedThe Mass Balance Study of LP-168 in Healthy Subjects
Clinical Pharmacology
Phase 12023-12-25
CompletedA Food Effect Study of LP-168 Tablets in Healthy Subjects
Mantle Cell Lymphoma
Phase 12023-06-21
Active Not RecruitingA Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma
Mantle Cell Lymphoma (MCL)
Phase 22023-02-21
UnknownA Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MD
Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
Phase 12023-02-14
CompletedA Study of LP-168 in Healthy Volunteers
Multiple Sclerosis, NMO Spectrum Disorder
Phase 12022-05-14
Active Not RecruitingA Study of LP-128 Capsules in Healthy Subjects
Chronic Hepatitis b
Phase 12021-11-19
CompletedA Study of LP-118 in Patients With Advanced Tumors
Solid Tumor, Lymphoma, Non-Hodgkin
Phase 12021-09-08
RecruitingA Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
B-cell Lymphoma
Phase 12021-07-06